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Abstract
Pregnancy-speciﬁc glycoproteins are secreted by immunoglobulin superfamily mem-
bers encoded by multigene families in eutherian mammals with haemochorial placen-
tation. They are expressed predominantly in placental trophoblast and exhibit im-
munomodulatory, anti-platelet, and pro-angiogenic functions. An inversion of Psg22 in
the mouse locus is associated with relatively high Psg22 expression in the ﬁrst half of
the pregnancy. Bioinformatic analyses of 17 mouse strains indicated that Psg22 inver-
sion arose at least 1.7 MYA. We used CRISPR-Cas9 mutagenesis to generate Psg22-null
mutants, two ofwhichwere analysed in detail (Psg22Δ10and Psg22Δ16). Bothmutants con-
tain frame-shifting deletions in exon 2, resulting in premature stop codons, and Psg22
mRNA was virtually undetectable. Both mutants are fertile and there was no distortion
of Mendelian ratios in heterozygous crosses. Housing of pregnant females in a hypoxic
(11% O2) environment for 5 (E5–E10) or 10 (E5–E15) days did not induce diﬀerential
growth or survival of Psg22 wildtype and null mutant genotypes. Our results indicate
that Psg22 is dispensable for embryonic development and reproduction under labora-
tory conditions. As PSGs are secreted into maternal blood, future work will focus on
whether Psg22 deﬁciency alters maternal physiology.
Introduction
Pregnancy-speciﬁc glycoproteins (PSG) are abundantly secreted by placental tro-
phoblast into the maternal bloodstream during human pregnancy, and their deregula-
tion is implicated in gestational disease [1] [2]. PSGs aremembers of the immunoglob-
ulin superfamily and are closely related to the predominantly membrane-anchored car-
cinoembryonic antigen-related cell adhesion molecules (CEACAM) [3] [4]. PSGs are
encoded by 17 genes in the mouse and 11 in the human [5] [6]. PSG gene families are
rapidly evolving and PSG protein domain organisation diﬀers between the mouse and
human, with no discernible orthologous relationships. However, PSG functions appear
to be conserved with evidence of roles in immune regulation, TGFβ1 activation, platelet
regulation, and angiogenesis [7] [8] [9] [10] [11] [6]. Therefore, mouse Psg gene mu-
tants may provide models of human gestational disease. PSG mRNA in the ﬁrst half
of mouse pregnancy is almost exclusively derived from Psg22 in trophoblast giant cells
(TGC), which may be due toinversion of the Psg22 gene and duplication of a long non-
coding RNA (lncRNA) within the Psg locus [12] [13]. This expression pattern facilitates
ablation of mouse Psg expression at this developmental stage without having to delete
multiple Psg genes.
Objective
We used CRISPR-Cas9 genome editing to produce and characterise mouse Psg22-null
mutants. We examined oﬀspring genotype ratios at birth in normal pregnancy and in
pregnancy with hypoxic stress, and we analysed placental weights and structure at E17
of gestation.
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a
Figure Legend
Figure 1. Psg22-null mutants are viable and fertile.
(A) Psg22 exon 2 (red text) with ﬂanking intronic sequences (plain text). CRISPR-Cas9
target sequence (green text) and primers used to amplify targeted region (yellow high-
light).
(B) Wildtype (Psg22WT) and mutant (Psg22Δ10, Psg22Δ16) DNA sequences at exon 2
CRISPR-Cas9 target site. Deleted regions are in red. G⇔C substitution in green. Se-
quences comprising premature stop codons (TGA) are underlined.
(C) Psg22 mRNA expression in wildtype and mutant E17 placentas. Combinedrepresen-
tative data from one sample from each mutant (n=2); wildtype (n=2). Data are mean ±
S.E.M; ** p<0.01, paired t-test (t(DF): t(5)=-5.318).
(D) Progeny genotype ratios from crosses of heterozygous parents under normoxic and
hypoxic conditions did not depart fromMendelian expectations; Chi-square test, p>0.05
for all comparisons. Number of progeny in parenthesis.
(E)Wildtype (n=3) and mutant (n=3 for each mutant) E17 placenta weights, and ratios
of spongiotrophoblast to labyrinthine trophoblast. There was no diﬀerence between
genotypes for any of the parameters measured, One-way ANOVA, p>0.05 (weight:
F (2,9)=0.780; spong-total:F (2,9)=0.524; lab-total: F (2,9)=0.524; ratio: F (2,9)=0.569.
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(F) Representative examples of wildtype and mutant E17 placentas. la, labyrinthine
trophoblast; sp, spongiotrophoblast. Scale bar = 1 mm.
Bioinformatics
A dataset of 17 mouse strains [14] [15] was assembled from the Sanger Institute website
(ftp://ftp-mouse.sanger.ac.uk/REL-1504-Assembly), as follows: 129SI_SvlmJ, AJ, AKR_-
J, Balb_cJ, C3H_HeJ, C57BL_6NJ, Cast_EiJ, Caroli_EiJ, CBA_J, DBA_2J, FVB_NJ, LP_J,
NOD_ShiLtJ, NZO_HlLtJ, PWK_PhJ, Spretus_EiJ, WSB_EiJ. The region known to con-
tain the Psg cluster, i.e. region 15,000,000–22,000,000 on chromosome 7, was extracted
from all mouse strains from the whole-genome ﬁle using a custom Bash script. Psg gene
sequences were obtained from Ensembl [23] for the mouse reference strain C57BL/6J,
and these were used as the query sequences in the subsequent sequence similarity
searches. Nucleotide BLAST [24] was used to obtain Psg gene sequences from all mouse
strains using the annotated Psg sequences from C57BL/6J. Coordinates from the BLAST
search allowed localisation of the queried Psg genes on either leading or lagging strand
in the diﬀerent strains.
CRIPSR-Cas9 vector cloning and validation
Psg22 targeting oligonucleotides were selected using CHOPCHOP (https://chop-
chop.rc.fas.harvard.edu) and were chosen from exon 2 of the Psg22 to disrupt the ORF.
Oligonucleotides (Euroﬁns MWG Operon, Eberberg, Germany) were cloned into px458
CRISPR vectors (www.addgene.org) using Zhang laboratory protocol (www.genome-
engineering.org/crispr/) [25]. The px458-Psg22 vector was tested in the NIH-3T3 cell
line using transient transfection with 3 µL Turbofect transfection reagent. 72 h post-
transfection, cells were harvested and genomic DNA was extracted using QIAGEN
DNeasy Blood and Tissue kit. 10 ng DNA was used as template for PCR reaction us-
ing Psg22 speciﬁc primers spanning the CRISPR target site; the resulting PCR products
were analysed for successful genome editing using Surveyor nuclease Cel I assay kit
(Integrated DNA Technologies, www.idtdna.com).
Psg22 -mutant mouse production
Male parental B6D2F1 mice and female B6D2F1 zygote donor mice were obtained
from DBA/2 and C57BL/6J breeding pairs. B6D2F1 females were superovulated at
6–10 weeks of age by intraperitoneal injection of 5 IU pregnant mare’s serum go-
nadotropin (PMSG) and 5 IU human chorionic gonadotropin (hCG) 48 h apart. Di-
rectly after hCG injection, the superovulated females were mated to B6D2F1 males.
CD1 pseudopregnant females were set up in the afternoon of day 1 by mating with
vasectomised CD1 males. The following morning (day 0.5 postcoitum; embryonic day
1, E1), B6D2F1 zygotes were harvested and placed in M16 drops in a humidiﬁed 5%
CO2 incubator at 37℃. The vector px458-Psg22 was diluted to 5 ng/µL in microin-
jection buﬀer (8 mM Tris-HCl, 0.15 mM EDTA). Pronuclear microinjection was car-
ried out in a drop of M2 medium under mineral oil. The same day, 72 microinjected
zygotes were surgically transferred into the oviducts of 3 CD1 pseudopregnant fe-
males. Each CD1 female was bilaterally transferred with 24 microinjected zygotes.
25 weaned oﬀsprings were ear-clipped and genotyped. Genotyping primers were de-
signed using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to am-
plify a 606-bp Psg22- speciﬁc product spanning the CRISPR-Cas9 target site. Geno-
typing primers were Psg22-2F 5′-CAGAAACAACACCATGTGAGT-3′ and Psg22-2R
5′-AGACACAATGCAGAGGGAAATA-3′. PCR products were puriﬁed (QIAGEN PCR
puriﬁcation kit) and directly sequenced (GATC, Koln, Germany).
Hypoxia treatment of pregnant mice
Commencing at E5 of pregnancy, female mice were housed in standard cages placed
in commercial environmental chambers with precise control of ambient oxygen con-
centration (Oxycycler, Biospherix, NY) [19] [22] which was maintained at 11% balance
nitrogen for 5 or 10 consecutive days (until E10 or E15, respectively). On removal from
hypoxia, mice were housed under normal husbandry conditions in room air until E17
or E18.
Quantitative reverse transcription polymerase chain reaction
First-strand cDNA was synthesised using 1 µg total RNA in a 20 µL re-
action using random hexamer priming and the High Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems, UK). Quantitative RT-PCR (qRT-
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PCR) primers were designed to give unbiased ampliﬁcation of Psg22 tran-
scripts: Psg22-QRT-F 5′-CGCATGGCCAGTTGGCCATT-3′ and Psg22-QRT-
R 5′-AAAGCGGGGGAAATAGTTGTAGTA-3′. Hypoxanthine guanine phosphori-
bosyltransferase (Hprt) expression was used to normalise mRNA input and cDNA
synthesis eﬃciency using primers: Hprt-F: 5’-CTATAAGTTCTTTGCTGACCTGCT-
3’; Hprt-R: 5’-ATCATCTCCACCAATAACTTTTATGT-3’. qRT-PCR was carried out in
triplicated 20 µL reactions using SYBR Green PCR Master Mix (Applied Biosystems,
UK), 1 µL cDNA, and primers at 600 mM using the ABI PRISM 7900HT instrument.
PCR cycle was initial denaturation (95℃ for 10 min), ampliﬁcation and quantiﬁcation
repeated for 40 cycles (95℃ for 45 s, 60℃ for 30 s, and 72℃ for 60 s with a single contin-
uous ﬂuorescence measurement), followed by a melting curve program (60–95℃, with
a heating rate of 1℃ per 30 s and a continuous ﬂuorescence measurement). Mouse E15
placental cDNA was used to produce the standard curve. PCR products were identiﬁed
by generating a melt curve, and results were expressed as mean Psg22 expression
relative to mean Hprt expression.
Histology
Placental weights were measured after ﬁxation in 4% paraformaldehyde (in phosphate
buﬀered saline at pH 7.4). Samples were then dehydrated and embedded in paraﬃn
wax. 5 mm thick sections were cut on a Leica RM2125RT microtome and stained with
hematoxylin/eosin and viewed using an adapted Zeiss Jena Microﬁlm Reader ﬁtted with
a 17.5x projector lens. Simple point counting methods were used to estimate the volume
fraction of spongiotrophoblast and the labyrinthine trophoblast compartments [26] [27].
Statistical analyses were implemented in Microsoft Excel. Results & Discussion
To determine whether inversion of Psg22 relative to ﬂanking Psg genes is a recent event
conﬁned to a limited number of laboratory strains, or an older variant that may predate
divergence of major mouse strains and indeed species, we surveyed theMouse Genomes
Project [14] [15]. Psg locus genomic sequences of 17 mouse strains were analysed by
sequence similarity searches, genomic location, and alignment. We found Psg22 inver-
sion in 16 of 17 mouse strains analysed (129SI_SvlmJ, AJ, AKR_J, Balb_cJ, C3H_HeJ,
C57BL_6NJ, Cast_EiJ, CBA_J, DBA_2J, FVB_NJ, LP_J, NOD_ShiLtJ, NZO_HlLtJ, PWK_-
PhJ, Spretus_EiJ, WSB_EiJ), including the most early diverging M. spretus; the Psg22
transcript could not be clearly identiﬁed in theM. caroli/EiJ strain due to poor sequence
quality. This phylogenetic distribution most likely indicates an inversion of Psg22 at
least 1.7 million years ago that has been maintained in the mouse clade. Therefore, this
inversion may underpin a placenta phenotype or inﬂuence fetal growth or survival.
We have produced Psg22-null mutant mouse strains by pronuclear microinjection of
fertilised oocytes with a CRISPR-Cas9 pX458 vector targeting a site in the Psg22 open
reading frame (ORF) in the exon 2 (Fig. 1A), which was previously tested for activity in
the NIH-3T3 embryonic ﬁbroblast cell line (data not shown). 72 microinjected B6D2F2
zygotes were transferred to oviducts of 3 CD1 pseudopregnant female recipients, and 25
oﬀsprings were ear-clipped for identiﬁcation and DNA extraction. PCR genotyping was
performed using Psg22 gene-speciﬁc primers ﬂanking the CRISPR target site, followed
by Cel I assay and direct sequencing of Cel I assay-positive PCR products. 8 progeny had
mutations, and BLAST alignment indicated that 5 were genetic mosaics, 2 had deletions
of 10 and 16 bp, respectively, and 1 had a 16 bp deletion just 3′ of a 1 bp substitution.
We selected 2mutant founders for breeding: onewith a 10 bp deletion (Psg22Δ10) and one
exhibiting a 16 bp deletion 3’ of a 1 bp substitution (Psg22Δ16) (Fig. 1B). Both mutations
are predicted to cause a frameshift resulting in a premature stop codon and were asso-
ciated with greatly reduced mRNA levels (Fig. 1C), possibly due to nonsense-mediated
decay.
Both founders were backcrossed to the C57BL/6 strain for two generations (to give
an average of 87.5% C57BL/6 background) before intercrossing heterozygous male and
female littermates of the Psg22Δ10 and Psg22Δ16 strains to determine genotype trans-
mission ratios. Combining the data from the two Psg22-mutant strains, there were 115
oﬀsprings: 28 homozygous wildtype, 30 homozygous null, and 57 heterozygotes, consis-
tent with Mendelian expectations, and suggesting that Psg22 is not essential for the de-
velopment (individual strain data and the statistics are given in ﬁgure 1D). Subsequent
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breeding of the Psg22Δ10/Δ10 and Psg22Δ16/Δ16 homozygotes conﬁrmed that these geno-
types are fertile (data not shown). This suggests that Psg22 is dispensable for fertility
and reproduction under laboratory conditions.
Previous reports indicate that reproductive phenotypes may be elicited by applying
stressors such as hypoxia to pregnancy in mouse strains with the mutations of placenta-
expressed genes [16] [17] [18]. We intercrossed heterozygous male and female litter-
mates of the Psg22Δ10 and Psg22Δ16 strains as described above and, using environmental
chambers, applied hypoxic stress (11%O2) to pregnant females for either 5 days (E5–E10)
or 10 days (E5–E15). At E17 or E18, pregnant [females were sacriﬁced and embryos were
genotyped and corresponding placentas were ﬁxed, weighed, and analysed using stere-
ological techniques. Similar to unstressed pregnancies, there was no deviation from
expected Mendelian ratios (Fig. 1D), and there was no diﬀerence in placental weight
and anatomy among the genotypes (Fig. 1E and F), indicating that Psg22 expression is
dispensable for successful pregnancy under hypoxic conditions.
Conclusions
We show that the inverted orientation of the Psg22 gene relative to ﬂanking Psg genes
is conserved in multiple mouse strains, suggesting that it originated at least 1.7 mil-
lion years ago. Unlike the Prolactin family gene PLP-A [17], Psg22-null mutants are
viable under both normoxic and hypoxic conditions of pregnancy, with no distortion of
Mendelian ratios in heterozygous crosses and no detectable placental phenotype.
Limitations
We did not analyse Psg22 protein expression in our Psg22 mutants due to lack of a
validated anti-Psg22-speciﬁc antibody. However, this deﬁcit is oﬀset by our ﬁnding of
very low levels of Psg22 mRNA in the mutants. We did not analyse maternal gestational
physiology in Psg22 mutant strains. However, unlike human PSGs that are present at
high levels inmaternal blood, mouse PSGs appear to be rapidly degraded in thematernal
bloodstream and do not exhibit signiﬁcant steady-state levels [13] [18] [19], suggesting
that a signiﬁcant eﬀect on maternal physiology may be unlikely.
PSG gene families may have evolved due to maternal-fetal conﬂict, and a prediction of
this theory is that high expression levels of conﬂictor genes may result from mutually
antagonistic interactions, but with a small net eﬀect on phenotype [20] [21]. A corol-
lary is that, notwithstanding high expression, deletion of the entire Psg locus may not
result in a signiﬁcant mutant phenotype. This argument is supported by the observa-
tion of high Psg mRNA expression in the placental trophoblast with rapid turnover of
Psg protein in the maternal circulation [12] [19] [22]. Therefore, a more informative
experiment may be to overexpress the Psg proteins in transgenic mouse models under
the hypothesis that excess Psg protein may swamp maternal mechanisms for removing
Psg from the circulation.
Additional Information
Methods
Bioinformatics
A dataset of 17 mouse strains [14] [15] was assembled from the Sanger Institute website
(ftp://ftp-mouse.sanger.ac.uk/REL-1504-Assembly), as follows: 129SI_SvlmJ, AJ, AKR_-
J, Balb_cJ, C3H_HeJ, C57BL_6NJ, Cast_EiJ, Caroli_EiJ, CBA_J, DBA_2J, FVB_NJ, LP_J,
NOD_ShiLtJ, NZO_HlLtJ, PWK_PhJ, Spretus_EiJ, WSB_EiJ. The region known to con-
tain the Psg cluster, i.e. region 15,000,000–22,000,000 on chromosome 7, was extracted
from all mouse strains from the whole-genome ﬁle using a custom Bash script. Psg gene
sequences were obtained from Ensembl [23] for the mouse reference strain C57BL/6J,
and these were used as the query sequences in the subsequent sequence similarity
searches. Nucleotide BLAST [24] was used to obtain Psg gene sequences from all mouse
strains using the annotated Psg sequences from C57BL/6J. Coordinates from the BLAST
search allowed localisation of the queried Psg genes on either leading or lagging strand
in the diﬀerent strains.
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CRIPSR-Cas9 vector cloning and validation
Psg22 targeting oligonucleotides were selected using CHOPCHOP (https://chop-
chop.rc.fas.harvard.edu) and were chosen from exon 2 of the Psg22 to disrupt the ORF.
Oligonucleotides (Euroﬁns MWG Operon, Eberberg, Germany) were cloned into px458
CRISPR vectors (www.addgene.org) using Zhang laboratory protocol (www.genome-
engineering.org/crispr/) [25]. The px458-Psg22 vector was tested in the NIH-3T3 cell
line using transient transfection with 3 µL Turbofect transfection reagent. 72 h post-
transfection, cells were harvested and genomic DNA was extracted using QIAGEN
DNeasy Blood and Tissue kit. 10 ng DNA was used as template for PCR reaction us-
ing Psg22 speciﬁc primers spanning the CRISPR target site; the resulting PCR products
were analysed for successful genome editing using Surveyor nuclease Cel I assay kit
(Integrated DNA Technologies, www.idtdna.com).
Psg22 -mutant mouse production
Male parental B6D2F1 mice and female B6D2F1 zygote donor mice were obtained
from DBA/2 and C57BL/6J breeding pairs. B6D2F1 females were superovulated at
6–10 weeks of age by intraperitoneal injection of 5 IU pregnant mare’s serum go-
nadotropin (PMSG) and 5 IU human chorionic gonadotropin (hCG) 48 h apart. Di-
rectly after hCG injection, the superovulated females were mated to B6D2F1 males.
CD1 pseudopregnant females were set up in the afternoon of day 1 by mating with
vasectomised CD1 males. The following morning (day 0.5 postcoitum; embryonic day
1, E1), B6D2F1 zygotes were harvested and placed in M16 drops in a humidiﬁed 5%
CO2 incubator at 37℃. The vector px458-Psg22 was diluted to 5 ng/µL in microin-
jection buﬀer (8 mM Tris-HCl, 0.15 mM EDTA). Pronuclear microinjection was car-
ried out in a drop of M2 medium under mineral oil. The same day, 72 microinjected
zygotes were surgically transferred into the oviducts of 3 CD1 pseudopregnant fe-
males. Each CD1 female was bilaterally transferred with 24 microinjected zygotes.
25 weaned oﬀsprings were ear-clipped and genotyped. Genotyping primers were de-
signed using Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) to am-
plify a 606-bp Psg22- speciﬁc product spanning the CRISPR-Cas9 target site. Geno-
typing primers were Psg22-2F 5′-CAGAAACAACACCATGTGAGT-3′ and Psg22-2R
5′-AGACACAATGCAGAGGGAAATA-3′. PCR products were puriﬁed (QIAGEN PCR
puriﬁcation kit) and directly sequenced (GATC, Koln, Germany).
Hypoxia treatment of pregnant mice
Commencing at E5 of pregnancy, female mice were housed in standard cages placed
in commercial environmental chambers with precise control of ambient oxygen con-
centration (Oxycycler, Biospherix, NY) [19] [22] which was maintained at 11% balance
nitrogen for 5 or 10 consecutive days (until E10 or E15, respectively). On removal from
hypoxia, mice were housed under normal husbandry conditions in room air until E17
or E18.
Quantitative reverse transcription polymerase chain reaction
First-strand cDNA was synthesised using 1 µg total RNA in a 20 µL re-
action using random hexamer priming and the High Capacity cDNA Re-
verse Transcription Kit (Applied Biosystems, UK). Quantitative RT-PCR (qRT-
PCR) primers were designed to give unbiased ampliﬁcation of Psg22 tran-
scripts: Psg22-QRT-F 5′-CGCATGGCCAGTTGGCCATT-3′ and Psg22-QRT-
R 5′-AAAGCGGGGGAAATAGTTGTAGTA-3′. Hypoxanthine guanine phosphori-
bosyltransferase (Hprt) expression was used to normalise mRNA input and cDNA
synthesis eﬃciency using primers: Hprt-F: 5’-CTATAAGTTCTTTGCTGACCTGCT-
3’; Hprt-R: 5’-ATCATCTCCACCAATAACTTTTATGT-3’. qRT-PCR was carried out in
triplicated 20 µL reactions using SYBR Green PCR Master Mix (Applied Biosystems,
UK), 1 µL cDNA, and primers at 600 mM using the ABI PRISM 7900HT instrument.
PCR cycle was initial denaturation (95℃ for 10 min), ampliﬁcation and quantiﬁcation
repeated for 40 cycles (95℃ for 45 s, 60℃ for 30 s, and 72℃ for 60 s with a single contin-
uous ﬂuorescence measurement), followed by a melting curve program (60–95℃, with
a heating rate of 1℃ per 30 s and a continuous ﬂuorescence measurement). Mouse E15
placental cDNA was used to produce the standard curve. PCR products were identiﬁed
by generating a melt curve, and results were expressed as mean Psg22 expression
relative to mean Hprt expression.
Histology
Placental weights were measured after ﬁxation in 4% paraformaldehyde (in phosphate
buﬀered saline at pH 7.4). Samples were then dehydrated and embedded in paraﬃn
wax. 5 mm thick sections were cut on a Leica RM2125RT microtome and stained with
hematoxylin/eosin and viewed using an adapted Zeiss Jena Microﬁlm Reader ﬁtted with
a 17.5x projector lens. Simple point counting methods were used to estimate the volume
fraction of spongiotrophoblast and the labyrinthine trophoblast compartments [26] [27].
Statistical analyses were implemented in Microsoft Excel.
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